Frank Heemskerk

see also: https://www.doctor-me.eu/index.html
Changing the care process is vital to maintain high quality care in heart failure (HF). HF is one of the most prevalent chronic diseases, affecting 3,600,000 people in NWE today and >5,000,000 in 2025 due to population ageing. HF care is expensive (>3,600 €/y pp) and provided by healthcare professionals only. The burden of HF on healthcare labour and costs is unsustainable. Patient self-care may solve the problem but is unsupported in the… Show more

see also: https://www.doctor-me.eu/index.html
Changing the care process is vital to maintain high quality care in heart failure (HF). HF is one of the most prevalent chronic diseases, affecting 3,600,000 people in NWE today and >5,000,000 in 2025 due to population ageing. HF care is expensive (>3,600 €/y pp) and provided by healthcare professionals only. The burden of HF on healthcare labour and costs is unsustainable. Patient self-care may solve the problem but is unsupported in the value chain. Current HF-eHealth products do not replace care, are stand-alone and add-ons to standard care rather than supporting patients in self-care. Next-gen eHealth providing decision support and actively involving HF-patients will reduce costs (50%) and improve quality of care. This provides huge business potential for the healthcare value chain. Show less

FFH2.0 is a project, funded through FP7-Health, with senior partners across Europe and one of it's main objectives is to facilitate partnering between academia and SME in the Health sector. We train on the strategic opportunities that the H2020 program offers, the rules, we share good practises in proposal writing, help with consortium building, train on project and finance management, IPR and exploitation/commercialization, contract negotiation and we facilitate finding partners for EU… Show more

FFH2.0 is a project, funded through FP7-Health, with senior partners across Europe and one of it's main objectives is to facilitate partnering between academia and SME in the Health sector. We train on the strategic opportunities that the H2020 program offers, the rules, we share good practises in proposal writing, help with consortium building, train on project and finance management, IPR and exploitation/commercialization, contract negotiation and we facilitate finding partners for EU projects by organization of partnering events. More details and news on the project website. Show less

RIMI4AC, this project’s acronym, is short for “Improvement of research and innovation management capacity in Africa and the Caribbean for the successful stimulation and dissemination of research results”.

Funded by the Africa, Caribbean and Pacific (ACP) science and technology programme - itself supported by the ninth European Development Fund - the project runs for four years (2010-2013) on a budget of approximately three million Euros.
In that time we support the set-up of research… Show more

RIMI4AC, this project’s acronym, is short for “Improvement of research and innovation management capacity in Africa and the Caribbean for the successful stimulation and dissemination of research results”.

Funded by the Africa, Caribbean and Pacific (ACP) science and technology programme - itself supported by the ninth European Development Fund - the project runs for four years (2010-2013) on a budget of approximately three million Euros.
In that time we support the set-up of research and innovation management associations in Central and East Africa, and the Caribbean region, as well as strengthen existing structures in Southern and West Africa. It will also provide training and mentoring, resources and an information and communications network that research managers can draw on in support of their activities. Show less

The project aimed to consolidate the dialogue between the key stakeholders in Mexico and the European Union (EU) responsible for the scientific, technological and innovation (STI) cooperation, following up the efforts carried out by the first phase of UEMEXCYT, as well as improving the channel of communication and partnership among Mexico and EU Member States; proposing ways of optimizing the cooperation mechanisms and enhancing the collaborative work; raising awareness to foster the formation… Show more

The project aimed to consolidate the dialogue between the key stakeholders in Mexico and the European Union (EU) responsible for the scientific, technological and innovation (STI) cooperation, following up the efforts carried out by the first phase of UEMEXCYT, as well as improving the channel of communication and partnership among Mexico and EU Member States; proposing ways of optimizing the cooperation mechanisms and enhancing the collaborative work; raising awareness to foster the formation of partnership opportunities between STI communities from both sides.
UEMEXCYT2 was integrated by CONACYT, as coordinator, the Universitat Autonoma de Barcelona from Spain (UAB), the Institut de Recherche pour le Développement from France (IRD), the Agenzia de la Promozione della Ricerca Europea from Italy (APRE), the Deutsch Zentrum Fur Luft – Und Raumfahrt Ev from Germany (PT‐DLR), the Zentrum Fuer Soziale Innovation from Austria (ZSI), Research & Innovation Management Services (RIMS) and Centre d'Étude des Relations entre l'Union Européenne et l'Amérique Latine (CERCAL) both from Belgium.
A key and strategic aspect of the EU‐Mexico STI cooperation was the renewal of the Agreement for Scientific and Technology Cooperation for a new 5 year period (2010‐2015); the Agreement represents the principal commitment between the EU and Mexican authorities toward the consolidation of a ‘knowledge area’ among both regions.
Under this perspective, the UEMEXCYT2 project became a strategic actor in the process of constructing a structured collaborative agenda and disseminating the opportunities among the Mexican and the European research and innovation communities, also as an important instrument to support the policy dialogue with the EU, as well as for the coordination of the political dialogue at
bi‐regional level in the European Union – Latin‐America and the Caribbean (EU‐LAC) science and technology process. Show less

FFH is a project, funded through FP7-Health, with senior partners across Europe and one of it's main objectives is to facilitate partnering between academia and SME in the Health sector. We train on the strategic opportunities that the FP7 program offers, the rules, we share good practises in proposal writing, help with consortium building, train on project and finance management, IPR and exploitation/commercialization, contract negotiation and we facilitate finding partners for EU projects by… Show more

FFH is a project, funded through FP7-Health, with senior partners across Europe and one of it's main objectives is to facilitate partnering between academia and SME in the Health sector. We train on the strategic opportunities that the FP7 program offers, the rules, we share good practises in proposal writing, help with consortium building, train on project and finance management, IPR and exploitation/commercialization, contract negotiation and we facilitate finding partners for EU projects by organization of partnering events. More details and news on the project website. Show less